Results 111 to 120 of about 74,680 (298)

Management of severe bone loss in patients at risk of medication‐related osteonecrosis of the jaw with microsurgery and guided bone regeneration: A case study

open access: yesClinical Advances in Periodontics, EarlyView.
Abstract Background Medication‐related osteonecrosis of the jaw (MRONJ) is a challenging complication associated with antiresorptive medications. Its exact pathophysiology remains unclear, but dental extractions and infections are known triggers, complicating prevention, and treatment.
Pedro Franco Ferreira   +3 more
wiley   +1 more source

Somatization in Polypharmacy: Hiding in Plain Sight

open access: yesINNOVATIONS in Pharmacy
Polypharmacy and somatic symptom disorder (SSD) are common conditions clinicians see every day in practice. Polypharmacy is easy to identify and causation seems to be straightforward.
Michael J. Schuh, Garcia Susan
doaj   +1 more source

Polypharmacy or medication washout: an old tool revisited

open access: yes, 2011
Daniel A Hoffman1, Mark Schiller2, James M Greenblatt3, Dan V Iosifescu41Neuro-Therapy Clinic Inc, Denver, CO; 2Mind Therapy Clinic, 2299 Post Street, Suite 104A, San Francisco, CA; 3Comprehensive Psychiatric Resources, Waltham, MA; 4Mood and Anxiety ...
Schiller M   +3 more
core  

Genomic Insights Into Risperidone Treatment Outcomes in Children and Adolescents: Experience From a Psychiatric Hospital Serving Rural Youth

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Risperidone is a commonly used antipsychotic for treating psychiatric illness in children and adolescents. There is a large variability in risperidone response and discontinuation rates remain high. Pharmacogenomics offers the opportunity to improve risperidone outcomes, yet studies in pediatric populations are limited.
Jack W. Staples   +10 more
wiley   +1 more source

Association Between Polypharmacy and Frailty in Elderly Patients Receiving Care at a Public Hospital in South India

open access: yesBiomedical Sciences and Clinical Medicine
OBJECTIVE This study analyses the impact of polypharmacy on frailty among the elderly patients visiting the public sector hospitals. The present study was done to assess the frailty status of the elderly patients and to see whether the individuals ...
Hunsur Nagendra Vishwas   +7 more
doaj   +1 more source

Polypharmacy in older adults with human immunodeficiency virus infection compared with the general population

open access: yes, 2016
Mercedes Gimeno-Gracia,1 María José Crusells-Canales,2 Francisco Javier Armesto-Gómez,3 Vicente Compaired-Turlán,4 María José Rabanaque-Hernández5 1Pharmacy Department, Lozano Blesa University Clinical ...
Crusells-Canales MJ   +4 more
core  

Clinical Significance of Acute Kidney Injury in Idiosyncratic Drug‐Induced Liver Injury: A Multicentric Propensity Scores Matched Study

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Clinical significance of acute kidney injury in idiosyncratic drug‐induced liver injury: a multicentric propensity scores matched study. Evidence about the role of acute kidney injury (AKI) in idiosyncratic drug‐induced liver injury (DILI) is still scarce.
José María Pinazo‐Bandera   +15 more
wiley   +1 more source

Polypharmacy Practice Inquiry Project [PDF]

open access: yes, 2015
“The impending crisis, which has been foreseen for decades, is now upon us.The nation needs to act now to prepare the health care workforce to meet the care needs of older adults.” Institute of Medicine. Given the rising tide of people over the age of 65,
Skinner, Mary T
core   +1 more source

Failure to Reach a Consensus in Polypharmacy Definition: An Obstacle to Measuring Risks and Impacts—Results of a Literature Review

open access: yes, 2020
Najwa Taghy, 1 Linda Cambon, 2 Jean-Marie Cohen, 3 Claude Dussart 4 1Laboratory P2S (Health Systemic Process), University of Lyon, University Claude Bernard of Lyon 1, Lyon, EA4129, France; 2Research Chair in Prevention, University of Bordeaux, ISPED ...
Cohen JM, Taghy N, Dussart C, Cambon L
core  

Dispensing of actionable pharmacogenetic drugs among adults receiving cardiovascular disease medications in the Northern Netherlands: A serial cross‐sectional study

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
The extent of pharmacogenetic (PGx) drug dispensing among Dutch adults receiving medications for cardiovascular disease (CVD) is unknown. Using the University of Groningen IADB.nl pharmacy database, we performed a serial cross‐sectional study (2019–2023) to estimate the annual prevalence of PGx drug dispensing and annual rates of initiation.
Zhuolin Zhang   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy